Insight into Metabolic (1)H-MRS Changes in Natalizumab Induced Progressive Multifocal Leukoencephalopathy Brain Lesions

BACKGROUND: Progressive multifocal leukoencephalopathy (PML) is a severe complication of immunosuppressive therapies, especially of natalizumab in relapsing–remitting multiple sclerosis (MS). Metabolic changes within PML lesions have not yet been described in natalizumab-associated PML in MS patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Schneider, Ruth, Bellenberg, Barbara, Hoepner, Robert, Ellrichmann, Gisa, Gold, Ralf, Lukas, Carsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5591840/
https://www.ncbi.nlm.nih.gov/pubmed/28928709
http://dx.doi.org/10.3389/fneur.2017.00454

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5591840/
https://www.ncbi.nlm.nih.gov/pubmed/28928709
http://dx.doi.org/10.3389/fneur.2017.00454

Ejemplares similares